Mölnlycke® Health Care and Transdiagen announce research collaboration to drive innovation in wound care

Contributed by: PR Newswire

Tags

MölnlyckeHealthcare

More Like This

Mölnlycke® Health Care announces US $15m investment in next-generation enzymatic therapeutics company MediWound Ltd

Dawn Health and Merck are collaborating to support Growth Disorders care

Mölnlycke® Health Care acquires P.G.F. Industry Solutions GmbH, the manufacturer of Granudacyn®, a range of solutions for wound cleansing and moisturising

Mölnlycke and Ondine join forces against HAIs

PR Newswire associated0

First Breakthrough Study Highlights Superiority of MatriDerm® in Wound Healing

PR Newswire associated0

Neomorph Announces Multi-Target Collaboration with Novo Nordisk to Discover Novel Molecular Glue Degraders for Cardiometabolic and Rare Diseases

ACCESSWIRE associated0

New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim

WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers